Novo Nordisk (NVO) Cash US GAAP (year values) |
|||||||||
2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Cash | 17 485 000 000 | 17 485 000 000 | 23 574 000 000 | 23 574 000 000 | 30 230 000 000 | 62 654 000 000 | |||
Changes by years, y/y, % | +37% | 0% | +35% | 0% | +28% | +14.1% |
Novo Nordisk. Cash
Novo Nordisk. Cash, changes, %
Novo Nordisk (NVO) Cash US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
Cash | 36 408 000 000 | 47 595 000 000 | 30 230 000 000 | 9 303 000 000 | 62 654 000 000 | 62 654 000 000 | ||
Changes by years, y/y, % | +17% | +27% | +28% | -67% | +72% | |||
Changes by quarters, q/q, % | +31% | -36% | -69% | +573% |